Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Acquired Hemophilia a With Intramuscular Hematoma at an Unusual Age: A Case Report Publisher



Nourbakhsh SMK1 ; Bahadoram M2 ; Eskandarion S1 ; Hassanzadeh S2
Authors

Source: Russian Journal of Pediatric Hematology and Oncology Published:2022


Abstract

Background. Acquired factor VIII (FVIII) deficiency or acquired hemophilia A (AHA) is very uncommon in children. Patients with AHA usually present with abnormal or unexpected bleeding which may be life-threatening. These patients usually have unexplained, prolonged, and isolated activated partial thromboplastin time (aPTT). Consequently, FVIII activity should be immediately evaluated. Bleeding prevention is important in patients with AHA. Case report. We present a case of a previously healthy 13-year-old female who presented with intramuscular hematoma, soft tissue hemorrhage, and epistaxis who was eventually diagnosed with AHA. Conclusion. To our knowledge, the present report is one of the few reported cases of an Asian patient that was diagnosed with acquired hemophilia A at a young age. © 2022, Graphica Ltd. All rights reserved.
Related Docs
View other Related Docs
1. Genetic Analysis of Non-Severe Hemophilia a Phenotype With a Discrepancy Between One-Stage and Chromogenic Factor Viii Activity Assays, Transfusion and Apheresis Science (2021)
2. Discrepancy Between the Results of One-Stage and Chromogenic Factor Viii:C Assays in Patients With Mild/Moderate Hemophilia A, Blood Coagulation and Fibrinolysis (2020)
3. Congenital Combined Deficiency of Coagulation Factors: A Study of Seven Patients, Blood Coagulation and Fibrinolysis (2015)
Experts (# of related papers)
View all Related Experts
Gholamreza Toogeh (6)
Shaban Alizadeh (3)
Other Related Docs
4. Hla-Drb1*01:01, But Not Hla-Drb1:1503 or Hla-Drb1*11, Is Associated With Decreased Inhibitor Risk in Iranian Hemophilia a Patients, Transfusion and Apheresis Science (2019)
5. Health Care Resource Utilization and Cost of Care for Haemophilia a and B Patients in Iran, Transfusion and Apheresis Science (2016)
6. Bleeding Disorder of Unknown Cause: Results From Iranian Study, Transfusion and Apheresis Science (2023)
7. A Comparison of Efficacy Between Recombinant Activated Factor Vii (Aryoseven) and Novoseven in Patients With Hereditary Fviii Deficiency With Inhibitor, Clinical and Applied Thrombosis/Hemostasis (2016)
8. Relationship Between Single-Nucleotide Polymorphisms of Tumor Necrosis Factor Alpha, Interleukin-10, Factor Ii and Factor V With Risk of Inhibitor Development in Patients With Severe Hemophilia A, Cardiovascular and Hematological Disorders - Drug Targets (2019)
9. Acute Compartment Syndrome After Knee Synovectomy in a Patient With Hemophilia A, JBJS Case Connector (2019)
10. Risk and Management of Intracerebral Hemorrhage in Patients With Bleeding Disorders, Seminars in Thrombosis and Hemostasis (2022)
11. Tnfaip3 Mutation Causing Haploinsufficiency of A20 With a Hemophagocytic Lymphohistiocytosis Phenotype: A Report of Two Cases, Pediatric Rheumatology (2022)
12. Phylogenetic Analysis and Frequency Estimation of Htlv-1 Virus in Hemophilic Patients Refer to Iranian Comprehensive Hemophilia Care Center (Ichcc), Molecular Genetics# Microbiology and Virology (2023)
13. The Effect of T Helper (Th)/T Cytotoxic (Tc) Ratio on Disease Severity in Type a Hemophilia Patients, Human Antibodies (2021)
14. Prevalence of Rare and Common Bleeding Disorders in Kurdistan Province of Iran, Journal of Cellular and Molecular Anesthesia (2019)
15. Evaluation of Normal Range of Bleeding Scores in Healthy Iranian Adults Using the International Society on Thrombosis and Hemostasis Bleeding Assessment Tool, Iranian Journal of Blood and Cancer (2020)
16. Subarachnoid Hemorrhage in Congenital Factor X Deficiency: A Case Study and Literature Review, Iranian Red Crescent Medical Journal (2016)
17. Evaluation of Aryoseven Safety (Recombinant Activated Factor Vii) in Patients With Bleeding Disorders (An Observational Post-Marketing Surveillance Study), Iranian Journal of Pathology (2016)
18. Spectrum of Factor X Gene Mutations in Iranian Patients With Congenital Factor X Deficiency, Blood Coagulation and Fibrinolysis (2016)
19. A Randomized, Two-Armed, Double-Blind, Single-Dose, Cross-Over, Bioequivalence Clinical Trial to Compare Pharmacokinetic Parameters and Safety of Recombinant Human Factor Viii With Fc Fusion Produced by Aryogen Pharmed Company Versus Elocta® (Reference Product) in Previously Treated Patients With Severe Haemophilia A, Annals of Hematology (2025)
20. Parvovirus 4 in Individuals With Severe Hemophilia a and Matched Control Group, International Journal of Hematology-Oncology and Stem Cell Research (2021)